Choice of Pharmacotherapy for Acute Destructive Pancreatitis (Review)

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.33619/2414-2948/123/33
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This paper is devoted to a modern, promising, minimally invasive endovascular method for treating acute pancreatitis: prolonged regional arterial pharmacotherapy. The main methodological and technical issues are discussed, on which there is no consensus in the literature. This primarily concerns the purpose and indications of the method in question, the timing of its initiation and duration, the drugs used, and evidence of its effectiveness using modern methods of statistical analysis.